Why more innovative therapies are reaching patients first through clinical trials

resizeplus ksenia yakovleva yt6couf1gy0 unsplash

In recent years, clinical trials have become a major way in which patients gain access to innovative therapies and new treatments before they become widely available on the market. This is no coincidence; modern medicine is evolving at an extremely rapid pace, and the path from the laboratory to the pharmacy is precisely through the clinical trial.

What are clinical trials?

Clinical trials are tightly controlled medical studies that evaluate the effectiveness and safety of new drugs, biological therapies, medical devices or therapeutic approaches.

They are conducted according to international Good Clinical Practice (GCP) standards and approved by:

  • ethics committees
  • national regulatory authorities
  • international pharmaceutical companies or scientific organisations

No new therapy can be formally approved without going through clinical phases.

Why are innovative therapies first available through clinical trials?

1. This is the mandatory regulatory process

Any new therapy must go through Phases I, II and III before it is authorised for use. This means that patients in clinical trials are the first to get access to the latest medical developments.

2. Medicine is becoming more personalized

Many modern therapies are aimed at:

  • specific genetic profiles
  • certain biomarkers
  • specific disease subtypes

These types of precision treatments are often available precisely within the framework of a clinical trial before they are included in standard therapeutic protocols.

3. Some conditions have limited therapeutic options

In chronic, autoimmune or rare diseases, standard therapies sometimes do not give the expected result. In these cases, participation in a clinical trial may provide access to a new mechanism of action or an innovative therapeutic approach.

Are clinical trials safe?

A common issue is security. It is important to know that clinical trials are one of the most tightly regulated processes in medicine.

Participants pass:

  • detailed medical screening
  • constant medical supervision
  • regular laboratory and diagnostic tests

The patient has the right to terminate participation at any time. All risks and potential benefits are discussed in advance through the informed consent process.

What are the benefits for the patient?

In addition to access to an innovative therapy, participation in a clinical trial often includes:

  • regular medical monitoring
  • detailed diagnostics
  • follow-up by a specialized team
  • contribution to the development of medicine

For many patients, this means the possibility of treatment that would otherwise be available years later.

Who can participate in a clinical trial?

Each study has clearly defined inclusion and exclusion criteria. Eligible patients are:

  • correspond to a specific diagnosis
  • fall within a certain age range
  • have no contraindications according to the protocol

Selection is done carefully to ensure participant safety and the reliability of the results.

Conclusion

More and more innovative therapies are reaching patients first through clinical trials, because this is the mandatory and scientifically sound pathway for the implementation of new medical solutions. For certain patients, this represents a real opportunity to access advanced treatments under strict medical supervision.

Related articles

Ready for the next step to better health?

Contact us for a consultation, research information or partnership. We will assist you with care and professionalism.